Fetal exposure to isotretinoin-an international problem.

  title={Fetal exposure to isotretinoin-an international problem.},
  author={Facundo Garc{\'i}a-Bournissen and Lilach Tsur and Lee Hilary Goldstein and Arthur Staroselsky and Marina Avner and Farhan M. Asrar and Matitiahu Berkovitch and Gianluca Straface and Gideon Koren and Marco De Santis},
  journal={Reproductive toxicology},
  volume={25 1},
BACKGROUND Isotretinoin is a known teratogen. Pregnancy prevention programs aimed at minimizing isotretinoin exposure in pregnancy have been implemented in North America with limited success. OBJECTIVE To compare the management of fetal risk of isotretinoin in three countries, including information given to women, implementation of contraceptive methods, and pregnancy outcomes. METHODS Pregnant women exposed to isotretinoin who called teratogen information services (TIS) in Israel, Italy… CONTINUE READING

From This Paper

Topics from this paper.


Publications citing this paper.
Showing 1-10 of 13 extracted citations

Knowledge of community pharmacists about the risks of medication use during pregnancy in central region of Saudi Arabia.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society • 2017
View 1 Excerpt

Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne • 2016

Similar Papers

Loading similar papers…